Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 8Hodgkin Disease 4Lymphoma, Non-Hodgkin 2Recurrence 1Radiation Injuries 1Neurotoxicity Syndromes 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1HIV Infections 1

Interventions

Vincristine 4Prednisone 4Etoposide 4Doxorubicin 4Cyclophosphamide 4Rituximab 3Filgrastim 2prednylidene 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal doxorubicin 1ibrutinib 1etoposide phosphate 1deltacortene 1Ultrasonography 1Procarbazine 1Lomustine 1Lenalidomide 1Granulocyte Colony-Stimulating Factor 1Endoscopy 1Electrocardiography 1Echocardiography 1CT-P10 1Bronchoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, AIDS-Related × Procarbazine × Clear all
NCT01775475 2022-10-10

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

AIDS Malignancy Consortium

Phase 2 Completed
7 enrolled 14 charts
Lymphoid

Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡